More on pneumonia: Treatment of MRSA in community acquired pneumonia

BMJ 2006; 332 doi: 10.1136/bmj.332.7553.1334 (Published 1 June 2006)
Cite this as: BMJ 2006;332:1334.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. James Greig (James.Greig@PHNT.swest.nhs.uk), consultant microbiologist,
  2. Peter Jenks, consultant microbiologist
  1. Department of Microbiology, Derriford Hospital, Plymouth PL6 8DH
  2. Department of Microbiology, Derriford Hospital, Plymouth PL6 8DH

    EDITOR—Hoare and Lim's update on the diagnosis and management of community acquired pneumonia does not mention methicillin resistant Staphylococcus aureus (MRSA),1 which is becoming more common in the community as a true community associated organism, in patients in residential care, and in those discharged from hospital. Patients who have newly acquired MRSA often develop further infections unless carriage is cleared. One study showed that in the 18 months after first colonisation, over one quarter of individuals developed further MRSA infections, many of which were …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL